Can a med spa in Utah offer compounded semaglutide or tirzepatide?
Facility · part of The Practice Perimeter
Short answer
The cited rules do not settle this — they only define compounding, excluding a pharmacist's or intern's preparation of a drug in a manufacturer-available dosage form at prescribed quantities and strengths; nothing addresses what a med spa may offer.
Utah answers the compounded-semaglutide question by exclusion, and the exclusion is the sharpest on this pass. "Compounding" does not include the preparation by a pharmacist or pharmacy intern of any prescription drug in a dosage form which is regularly and commonly available from a manufacturer in quantities and strengths prescribed by a practitioner Semaglutide and tirzepatide are regularly and commonly available from their manufacturers, so preparing them in the marketed dosage form is not compounding in Utah at all — it falls outside the definition rather than inside it on conditions.
Utah Code § 58-17b-102(18)(b)(ii) (preparing a commercially available drug is NOT compounding) · verified Sep 7, 2026 · regulatory monitoring, not legal advice
Related Utah rules
The supply-chain route is excluded in the same subsection. "Compounding" does not include the preparation of prescription drugs by a pharmacist or pharmacy intern for sale to another pharmacist or pharmaceutical facility — so a pharmacy preparing stock to sell on to a clinic is not compounding either.
Utah Code § 58-17b-102(18)(b)(i) (…nor is preparing drugs for sale to another pharmacy or facility) · verified Sep 7, 2026
The positive definition has three limbs and bounds the quantity from the first word. "Compounding" means the preparation, mixing, assembling, packaging, or labeling of a limited quantity drug, sterile product, or device: (i) as the result of a practitioner's prescription order or initiative based on the practitioner, patient, or pharmacist relationship in the course of professional practice; (ii) for the purpose of, or as an incident to, research, teaching, or chemical analysis and not for sale or dispensing; or (iii) in anticipation of prescription drug orders based on routine, regularly observed prescribing patterns.
Utah Code § 58-17b-102(18)(a) (the three limbs, including anticipatory stock) · verified Sep 7, 2026
How other states answer this
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Related Utah questions
- Is an exam required before a patient can be treated in Utah?
- Can the pre-treatment exam be done by telehealth in Utah?
- Must someone be on site while a patient is treated in Utah?
Get Utah changes as they publish
We scan the Utah legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All Utah rules and changes · MedSpaRadar is regulatory monitoring and reference: it summarizes public laws, regulations and agency actions and links each to its source. It is not legal, medical, or compliance advice, and using it creates no attorney-client relationship. A summary can lag its source or leave out detail, and monitoring itself can be interrupted — so an absence of alerts means nothing reached you, not that nothing happened. Read the cited source, check its effective date, and confirm any change to your operations or clinical practice with qualified health-law counsel and your medical director. Legislative data via LegiScan (CC BY 4.0).